This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Levetiracetam Treatment of Neonatal Seizures: Safe...
Clinical trial

Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study (LEVNEONAT1)

Read time: 1 mins
Last updated:27th Aug 2014

LEVNEONAT is a multicentre French clinical trials with the aim to develop new treatment strategies for the treatment of neonatal seizures using Levetiracetam. The purpose of this study is to determine the correct dosing, safety and efficacy for intravenous levetiracetam as first line treatment in term new born babies with seizures. This new anticonvulsivant drug is a promising treatment for seizures in newborns.

Category Value
Study start date 2014-08-27

View full details